Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study by Lori-Ann Linkins,

Slides:



Advertisements
Similar presentations
A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in.
Advertisements

High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass by Grace M. Lee, Ian J. Welsby,
Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications by Elias Campo, Steven H. Swerdlow, Nancy L.
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases by Porcia T. Bradford, Susan S. Devesa, William F. Anderson,
Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura by Donald M. Arnold, Ishac Nazi, Aurelio Santos,
Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients by.
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis by Marcello Di Nisio, Anne W. S. Rutjes, Noemi.
Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses by Klaus Juul, Anne Tybjærg-Hansen, Rolf Steffensen, Steen Kofoed, Gorm Jensen, and.
Determination of acute lung injury after repeated platelet transfusions by Laurence Corash, Jin Sying Lin, Claire D. Sherman, and Joseph Eiden Blood Volume.
Elvira Maličev Blood Transfusion Centre of Slovenia
Volume 144, Issue 4, Pages (October 2013)
Sarah Caton, Elly O'Brien, Annie Jullien Pannelay, Robert G. Cook
by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E
by Nadine Martel, James Lee, and Philip S. Wells
TCR-MHC-peptide(s): in vivo veritas
Multiple Myeloma: Interleukin-15 Antagonizes Bone Morphogenetic Protein-Induced Apoptosis and Growth Inhibition. by Magne Rekvig, Anne-Tove Brenne, Torstein.
Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura
Pacritinib, a Dual JAK2/FLT3 Inhibitor: An Integrated Efficacy and Safety Analysis Of Phase II Trial Data In Patients With Primary and Secondary Myelofibrosis.
Treatment and Prevention of Heparin-Induced Thrombocytopenia
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study by Yu Wang, Qi-Fa Liu, Lan-Ping Xu, Kai-Yan Liu,
The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial by Anne M. Kelly, Stephen F. Garner, Theodora.
How I treat elderly patients with myeloma
Validation of the Nordic Scoring System for Erythropoietic Stimulating Agents in MDS Using IWG 2006 Erythroid Response Criteria by Jennifer Jayakar, Richard.
Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,
An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim.
Nonmyeloablative conditioning for relapsed follicular lymphoma
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with.
by Daniel W. Bougie, Ana I. Benito, Luis I
Genetic sequence analysis of inherited bleeding diseases
by Jessica A. Reese, Xiaoning Li, Manfred Hauben, Richard H
Taking a leaf from the book of oral tolerance
Theodore E. Warkentin, MD  The American Journal of Medicine 
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
ROCK and Rho(ll) in bone marrow
IV Immunoglobulin for Autoimmune Heparin-Induced Thrombocytopenia
Has MRD monitoring superseded other prognostic factors in adult ALL?
Incidence and Predictors Of Venous Thromboembolism Among Lymphoma Patients In Denmark: A Nationwide Population-Based Cohort Study by Jennifer L Lund, Lene.
HU for acute treatment of sickle VOC?
Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,
How I treat catastrophic thrombotic syndromes
Heparin-Induced Thrombocytopenia in Patients with Ventricular Assist Devices: Are New Prevention Strategies Required?  Theodore E. Warkentin, MD, Andreas.
When is HIT Really HIT? The Annals of Thoracic Surgery
The Molecular Pathology of Primary Immunodeficiencies
Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial by Jessica C. Cardenas, Xu Zhang, Erin.
Heparin-induced thrombocytopenia and cardiac surgery
Platelet spreading on immobilized fibrinogen.
Platelet ATP secretion in response to agonist stimulation.
Immunoblots of PLCβ isoforms in wild-type and PLCβ2/β3-null platelets.
Actin assembly in response to thrombin.
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
Treatment algorithm for management of CRS based on the revised CRS grading system. Treatment algorithm for management of CRS based on the revised CRS grading.
How I treat thrombocytopenia in pregnancy
Impact of age on clinical risk scores in follicular lymphoma
Heparin-induced thrombocytopenia
Rituximab immunotherapy: it’s getting personal
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
How I treat heparin-induced thrombocytopenia and thrombosis
The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera by Nikolai A. Podoltsev, Mengxin.
A binding relationship with thrombin
Hepatosplenic T-Cell Lymphoma: Clinicopathological Features and Treatment Outcomes: Report From The North American Peripheral T-Cell Lymphoma Consortium.
Full Uncapped Doses Of Chemotherapy In Non-Hodgkin's Lymphoma Patients With a High Body Surface Area Are Well Tolerated With No Increase In Toxicity, and.
A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score by Dana E. Angelini, M. Todd Greene, Julie.
Initial treatment of CLL: integrating biology and functional status
by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal
Balancing bleeding in brain metastases
Cold agglutinin disease
A schematic diagram showing the mechanism by which L5 triggers platelet activation and aggregation. A schematic diagram showing the mechanism by which.
Presentation transcript:

Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study by Lori-Ann Linkins, Shannon M. Bates, Agnes Y. Y. Lee, Nancy M. Heddle, Grace Wang, and Theodore E. Warkentin Blood Volume 126(5):597-603 July 30, 2015 ©2015 by American Society of Hematology

Study flow. Study flow. Lori-Ann Linkins et al. Blood 2015;126:597-603 ©2015 by American Society of Hematology

Proposed suspected HIT algorithm Proposed suspected HIT algorithm. *Washed platelet HIPA could likely be used instead of an SRA, but we did not evaluate the washed platelet HIPA test in the current study. Proposed suspected HIT algorithm. *Washed platelet HIPA could likely be used instead of an SRA, but we did not evaluate the washed platelet HIPA test in the current study. Lori-Ann Linkins et al. Blood 2015;126:597-603 ©2015 by American Society of Hematology